Evidence mapPaperPMID 36296196Full record

ReviewMicroorganisms2022

BCG Vaccine-The Road Not Taken.

Coad Thomas Dow, Laith Kidess

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07094711 (Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG in Patients With Mycobacterium Avium Complex Lung Disease), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07094711 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG in Patients With Mycobacterium Avium Complex Lung Disease (BOOST)

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2028Enrolled48ConditionsMycobacterium Avium-intracellulare Infection, Mycobacterium Infections, NontuberculousArmsMycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine, preservative-free saline
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Coad Thomas DowDepartment of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, Madison, WI 53705, USA.ORCID 0000-0003-4301-6101
Laith KidessDepartment of Biochemistry, University of St. Thomas, St. Paul, MN 55105, USA.
Smith-Kettlewell Eye Research Institute · USUniversity of St. Thomas - Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Alzheimer’s diseaseBacillus Calmette-Guérin (BCG)global burden of diseasemolecular mimicrymultiple sclerosisMycobacterium avium ss. paratuberculosis (MAP)nonspecific effectsnon-tuberculous mycobacteria (NTM)Parkinson’s diseasetrained immunitytuberculosistype 1 diabetes

Identifiers

PMID36296196
PMCPMC9609351
OpenAlexW4297541893

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.